Assertio Holdings Inc (NAS:ASRT)
$ 1.255 -0.03 (-2.34%) Market Cap: 119.65 Mil Enterprise Value: 71.25 Mil PE Ratio: 0 PB Ratio: 0.91 GF Score: 66/100

Assertio Holdings Inc at Issuer Direct Winter Wonderland Best Ideas Investor Conference (Virtual) Transcript

Feb 08, 2022 / 03:00PM GMT
Release Date Price: $2.64 (-0.38%)
Operator

Good day, and welcome to the Second Annual Winter Wonderland Best Ideas Conference. The next presenting company is Assertio Holdings, Inc. (Operator Instructions)

I'd now like to turn the floor over to today's host, Daniel Peisert, President and CEO of Assertio Holdings, Inc. Sir, the floor is yours.

Daniel A. Peisert
Assertio Holdings, Inc. - President, CEO & Director

Thank you, Matthew, and we're honored to be presenting here today at the Winter Wonderland conference. Let me forward the slides here.

So at a high level, Assertio today is a commercial stage pharmaceutical company with 4 core products that serve as the foundation for our business. Their prescription products in large markets covering non-opioid pain, arthritis and inflammation and migraine. At the time we announced the Otrexup acquisition in December, we also increased our outlook for the full year of 2021 for both revenue and EBITDA. We now expect to exceed $108 million in revenue and exceed $48 million in adjusted EBITDA for 2021. This outlook is well above our initial

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot